Pedigree Analysis
Pleiotropy
Incomplete Dominance
Comparing Copy Number Variations and SNPs
Cystic Fibrosis: Pathogenesis
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jul 7, 2026

In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease
Published on: December 20, 2017
Marian A Kroos1, Janbernd Kirschner, Frank N Gellerich
1Department of Clinical Genetics, Erasmus MC, P.O. Box 1738, Rotterdam 3000 DR, The Netherlands.
Genetic factors and secondary influences can alter the presentation of Pompe disease. Extremely low acid alpha-glucosidase activity may lead to varied clinical outcomes, from infantile to childhood forms.
Area of Science:
Background:
Observation:
Findings:
Implications: